HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia

CompletedOBSERVATIONAL
Enrollment

4,336

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
HIV
Trial Locations (19)

10430

Site 530: University of Indonesia/ Dr. Cipto Mangunkusumo Hospital, Jakarta

10440

Site 640: St. Carolus Hospital, Jakarta

14340

Site 540: Penyakit Infeksi Sulianti Saroso Hospital, Jakarta

Site 590: Persahabatan Hospital, Jakarta

15111

Site 610 : RSU Kabupaten Tangerang, Tangerang

20136

Site 600 : Adam Malik Hospital, Medan

24415

Site 670 - RSUD Dr. Zainoel Abidin, Banda Aceh

40161

Site 510: University of Padjajaran/ Dr. Hasan Sadikin Hospital, Bandung

50244

Site 560: University of Diponegoro/ Dr. Kariadi Hospital, Semarang

55284

Site 580: University of Gadjah Mada/ Dr. Sardjito Hospital, Yogyakarta

60286

Site 570: University of Airlangga/ Dr. Soetomo Hospital, Surabaya

70125

Site 630: M. Ansari Saleh Hospital, Banjarmasin

75123

Site 660 RSUD Abdul Wahab Sjahranie, Samarinda

78111

Site 680 - RSUD dr Soedarso, Pontianak

80114

Site 520: University of Udayana/Sanglah Hospital, Denpasar

86113

Site 700 - RSUD Dr.TC Hillers, Maumere

90245

Site 550: University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital, Makassar

99351

Site 690 - RSUD Abepura, Jayapura

Unknown

Site 650: Budi Kemuliaan Hospital, Batam

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Ina-Respond

OTHER

NCT03663920 - HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia | Biotech Hunter | Biotech Hunter